Fluorescent treponemal antibody absorbtion (FTA-ABS) test: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''FTA-ABS''' is a treponemal test for [[Syphilis]]. Using antibodies specific for the [[Treponema pallidum]] species, such tests are more specific than Non-Treponemal testing such as [[VDRL]]. | '''FTA-ABS''' is a treponemal test for [[Syphilis]]. Using antibodies specific for the [[Treponema pallidum]] species, such tests are more specific than Non-Treponemal testing such as [[VDRL]]. | ||
| Line 10: | Line 9: | ||
This test is not useful for following therapy, because it does not wane with successful treatment of the disease, and will continue to be positive for the life of the patient after primary exposure. | This test is not useful for following therapy, because it does not wane with successful treatment of the disease, and will continue to be positive for the life of the patient after primary exposure. | ||
{{ | ==Related chapters== | ||
*[[Syphilis]] | |||
*[[VDRL|Venereal Disease Research Laboratory Test]] | |||
*[[RPR|Rapid Plasma Reagent Test]] | |||
==References== | |||
{{reflist|2}} | |||
[[Category:Blood tests]] | [[Category:Blood tests]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 17:45, 18 September 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
FTA-ABS is a treponemal test for Syphilis. Using antibodies specific for the Treponema pallidum species, such tests are more specific than Non-Treponemal testing such as VDRL.
FTA (Fluorescent Treponemal Antibody) - ABS (Absorption) should always be followed to confirm a positve RPR and/or VDRL test for syphilis. The ABS suffix refers particularly to a processing step used to remove nonspecific antispirochetal antibodies present in normal serum.
This test is not useful for following therapy, because it does not wane with successful treatment of the disease, and will continue to be positive for the life of the patient after primary exposure.
Related chapters
References